Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas-Reference-Cited by-同舟云学术

Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas

Published:2019-02 Issue:4 Volume:120 Page:435-443
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Brodin Bertha A.,Wennerberg Krister,Lidbrink Elisabet,Brosjö Otte,Potdar Swapnil,Wilson Jennifer N.,Ma Limin,Moens Lotte N.,Hesla Asle,Porovic Edvin,Bernhardsson Edvin,Papakonstantinou Antroula,Bauer Henrik,Tsagkozis Panagiotis,von Sivers Karin,Wejde Johan,Östling Päivi,Kallioniemi Olli,Stragliotto Christina Linder

Funder

Barncancerfonden

Cancerföreningen i Stockholm

Kurt and Lillian Sagens Stiftelse Liddy Shriver Sarcoma Initiative

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-018-0359-4.pdf

Reference28 articles.

1. Fletcher, C. D. M., Bridge, J. A., Hogendoorn, P. & Mertens, F. WHO Classification of Tumours of Soft Tissue and Bone 4th edn (IARC Press, Lyon, 2013).

2. Bramwell, V. H., Anderson, D., Charette, M. L., Sarcoma Disease Site G. Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma. Cochrane Database Syst. Rev. CD003293 3, (2003).

3. Le Cesne, A. et al. Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: a trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group. J. Clin. Oncol. 18, 2676–2684 (2000).

4. Verma, S. et al. Meta-analysis of ifosfamide-based combination chemotherapy in advanced soft tissue sarcoma. Cancer Treat. Rev. 34, 339–347 (2008).

5. Helman, L. J. & Meltzer, P. Mechanisms of sarcoma development. Nat. Rev. Cancer 3, 685–694 (2003).

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Pazopanib on Primary Patient-derived Undifferentiated Malignant Round Cell Sarcoma Line;Advances in Human Biology;2024-06-11

2. Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers;Nature Medicine;2024-04

3. Preclinical Models of Visceral Sarcomas;Biomolecules;2023-11-06

4. Functional Precision Medicine Enhances Clinical Outcomes of Relapsed/Refractory Pediatric and Adolescent Cancer Patients;2023-07-07

5. Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data;Nucleic Acids Research;2023-05-13